Diagnoptics News

What's new?

Read all news items about the AGE Reader and Diagnoptics.

Editorial confirms added value of AGE Reader in atherosclerosis

Groningen, the Netherlands – March 25, 2014.

Together with the recently published clinical paper by de Vos et al. (2014) an editorial paper from Ann Marie Schmidt has been published. In this editorial it is concluded that the paper by de Vos et al. (2014)  provides a formidable window into the association between the AGE Reader measurement, AGEs and mortality and major adverse cardiovascular events in peripheral artery disease. In addition the author of the editorial gives an excellent overview of the previous studies with the AGE Reader and illustrates the pathogenic importance of the AGE Reader measurement.

De Vos et al. (2014)

This publication demonstrates that the AGE Reader measurement is a strong predictor of mortality and  coronary events in patients with peripheral artery disease. The added value of the AGE Reader in predicting the cardiovascular risk of diabetes and renal failure was already well known. The present publication  extends its (independent and additive) predictive power to the much wider group of persons with atherosclerosis.

The abstract of this publication can be found here

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The 'AGE Reader mu' is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.